Painkiller Naproxen Not Safer Than Similar Drugs, FDA Advisory Panel Says

A Food and Drug Administration advisory panel Feb. 11 said there is no evidence that the painkiller naproxen is safer for the heart than other nonsteroidal anti-inflammatory drugs (NSAIDs).

At a joint meeting, the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee voted 16-9 that the available data don’t support a conclusion that naproxen has a lower risk of cardiovascular (CV) thrombotic events as compared to other NSAIDs, an FDA spokeswoman told Bloomberg BNA in a Feb. 11 e-mail. Naproxen is sold under the brand names Naprosyn and Anaprox by Genentech, a member of the Roche ...